1-5 of 5
Sunil S. Badve
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis

Melinda L. Telli, Charles Chu, Sunil S. Badve, Shaveta Vinayak, Daniel P. Silver, Steven J. Isakoff, Virginia Kaklamani, William Gradishar, Vered Stearns, Roisin M. Connolly, James M. Ford, Joshua J. Gruber, Sylvia Adams, Judy Garber, Nadine Tung, Chris Neff, Ryan Bernhisel, Kirsten M. Timms, Andrea L. Richardson
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2704–2710.
https://doi.org/10.1158/1078-0432.CCR-19-0664
Published: 01 June 2020
View articletitled, Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis
Open the PDF for Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis in another window
Journal Articles

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer

Anosheh Afghahi, Natasha Purington, Summer S. Han, Manisha Desai, Emma Pierson, Maya B. Mathur, Tina Seto, Caroline A. Thompson, Joseph Rigdon, Melinda L. Telli, Sunil S. Badve, Christina N. Curtis, Robert B. West, Kathleen Horst, Scarlett L. Gomez, James M. Ford, George W. Sledge, Allison W. Kurian
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (12): 2851–2858.
https://doi.org/10.1158/1078-0432.CCR-17-1323
Published: 14 June 2018
View articletitled, Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer
Open the PDF for Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B47: The role of ZNF217 in the development of breast cancer chemoresistance

Christopher Suarez, Sunil S. Badve, Laurie E. Littlepage
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): B47.
https://doi.org/10.1158/1557-3265.PMS14-B47
Published: 13 February 2015
View articletitled, Abstract B47: The role of ZNF217 in the development of breast cancer chemoresistance
Journal Articles

Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial

Bryan P. Schneider, Robert J. Gray, Milan Radovich, Fei Shen, Gail Vance, Lang Li, Guanglong Jiang, Kathy D. Miller, Julie R. Gralow, Maura N. Dickler, Melody A. Cobleigh, Edith A. Perez, Tamara N. Shenkier, Kirsten Vang Nielsen, Sven Müller, Ann Thor, George W. Sledge, Jr, Joseph A. Sparano, Nancy E. Davidson, Sunil S. Badve
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (5): 1281–1289.
https://doi.org/10.1158/1078-0432.CCR-12-3029
Published: 03 March 2013
View articletitled, Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
Open the PDF for Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial in another window
Includes: Supplementary data
Journal Articles

Impact of Preanalytic Factors on the Design and Application of Integral Biomarkers for Directing Patient Therapy

Stephen M. Hewitt, Sunil S. Badve, Lawrence D. True
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1524–1530.
https://doi.org/10.1158/1078-0432.CCR-11-2204
Published: 14 March 2012
View articletitled, Impact of Preanalytic Factors on the Design and Application of Integral Biomarkers for Directing Patient Therapy
Open the PDF for Impact of Preanalytic Factors on the Design and Application of Integral Biomarkers for Directing Patient Therapy in another window